Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Shares Outstanding (Weighted Average) (2022 - 2026)

Rallybio's Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $5.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 3.42% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 3.42% increase, with the full-year FY2025 number at $5.6 million, up 3.42% from a year prior.
  • Shares Outstanding (Weighted Average) hit $5.6 million in Q4 2025 for Rallybio, down from $44.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for RLYB hit a ceiling of $44.9 million in Q3 2025 and a floor of $5.4 million in Q4 2024.
  • Historically, Shares Outstanding (Weighted Average) has averaged $35.9 million across 4 years, with a median of $40.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): grew 27.11% in 2023 and later tumbled 86.54% in 2024.
  • Tracing RLYB's Shares Outstanding (Weighted Average) over 4 years: stood at $31.8 million in 2022, then increased by 27.11% to $40.4 million in 2023, then tumbled by 86.54% to $5.4 million in 2024, then grew by 3.42% to $5.6 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for RLYB at $5.6 million in Q4 2025, $44.9 million in Q3 2025, and $44.8 million in Q2 2025.